As FDA commissioner, Scott Gottlieb battled to lower the cost of prescription drugs and streamline approval of biosimilars. Now, Gottlieb is taking that fight to the private sector. In an interview with the Washington Post, Gottlieb, who will leave the Trump administration Friday, said he plans to take a fellowship with conservative think tank American Enterprise… Read More »
DEA / ALBERT CEOLANGetty Images Until a few minutes ago, I was blissfully ignorant of the body’s ability to emit a thick, white spoiled cheese-like substance that, when pinched delicately enough, blooms like a cursed rose from the depths of its pustule. Those were more innocent times, and I remember them fondly. Thanks to this… Read More »
Much has been said about the fact that the eyebrows are the frame of the face and, therefore, largely determine the features and expressions of a person. For this reason, when ageing and flaccidity affect the firmness of the skin of the eyebrows, it is important to look for an aesthetic alternative that will improve… Read More »
Siemens and SAS are partnering up for an artificial project that will develop new analytics for cloud and edge computing, combining SAS’ open source streaming analytics through Siemens’ MindSphere IoT platform. It’s one of two big AI partnerships announced this week by Siemens, whose Healthineers division is also working with Intel on a cardiac MRI… Read More »
Nearly 600 HIV activists gathered in the nation’s capital April 1 and 2 for AIDSWatch, the largest HIV advocacy event of the year. After a day and evening of conferences, meetings, networking sessions, speeches and awards (more on those later), participants rallied the morning of April 2 in front of the U.S. Capitol before splitting… Read More »